Gene Knockout Kit (human) - 1.5 nmol - GSDMD and 5 more items

The University of Virginia awarded a contract to EDITCO BIO, INC. on August 8, 2026, for the provision of specialized molecular biology research reagents. The contract, identified as A207_PO-0467068, carries a cumulative value of $1,475.00 and is being fulfilled in Virginia. Delivery of all line items is directed to Ryan M. Sangston at the University of Virginia.

The contract encompasses six distinct line items focused on gene knockout and gene editing technologies. The deliverables include a human Gene Knockout Kit (GSDMD variant) valued at $409, two mouse Gene Knockout Kits (Gsdme and Gsdmd variants) at $405 each, a Control Human AAVS1 Single-Guide short guide ribonucleic acid (sgRNA) in modified form at $102, a Positive Control Mouse Rosa26 modified single-guide ribonucleic acid at $99, and shipping and handling services at $55. These reagents are commonly used in genetic research applications to facilitate targeted gene modification and serve as controls for experimental validation.